| CENTESSA PHARMACEUTICALS |
| USA |
| Gesundheit |
| US1523091007 / A3CQ72 |
| 260 (Frankfurt) / CNTA (NASDAQ) |
| FRA:260, ETR:260, 260:GR, NASDAQ:CNTA |
| - |
| https://centessa.com/ |
|
Centessa Pharmaceuticals plc - ADR is a type of financial asset known as an American Depositary Receipt, representing shares in the UK-based biopharmaceutical company Centessa Pharmaceuticals plc. Designed to make it easier for U.S. investors to inve..
>Volltext.. |
| 3352.51 Mio. EUR |
| 3241.32 Mio. EUR |
| 13.09 Mio. EUR |
| -184.8 Mio. EUR |
| -210.34 Mio. EUR |
| -1.58 EUR |
| 102.77 Mio. EUR |
| 44.15 Mio. EUR |
| -157.22 Mio. EUR |
| 8.45 |
| 117.83% |
| -49.37% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 12.294.978 USD. |
| CENTESSA |
| 31.03.26 |
|